Product Information
DEXTROAMP-AMPHETAMIN 15 MG TAB is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.2370 per EA under NDC 42858072501. Its NADAC has been published 238 times since Feb 2, 2022.
FDA first approved this application on Jan 13, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
DEXTROAMP-AMPHETAMIN 15 MG TAB
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine SulfateStrength
3.75; 3.75; 3.75; 3.75 mg/1; mg/1; mg/1; mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858072501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA213111FDA Approved
1/13/2021
TE Code
AB
On Market Since
9/9/2021
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAMIN 15 MG TAB has been published 238 times since Feb 2, 2022, and over the history we have for it it has declined 11.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2370 per EA |
|---|---|
| All-time high | $0.3378 (Mar 15, 2023) |
| All-time low | $0.1838 (Nov 20, 2024) |
| 52-week high | $0.2936 |
| 52-week low | $0.2370 |
| Median price | $0.2676 |
| Average price | $0.2678 |
| Largest weekly change | +39.5% (Feb 22, 2023) |
| Weeks tracked | 238 |
| Tracking since | Feb 2, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAMIN 15 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 15 MG TAB, manufactured by Rhodes Pharmaceuticals L.P., is $0.2370 per EA (NDC 42858072501), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHETAMIN 15 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 15 MG TAB has declined 11.4%. It has been tracked across 238 weekly CMS publications since Feb 2, 2022.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 15 MG TAB?
Since Feb 2, 2022, the NADAC for DEXTROAMP-AMPHETAMIN 15 MG TAB has ranged from a low of $0.1838 (Nov 20, 2024) to a high of $0.3378 (Mar 15, 2023), with a median of $0.2676 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 15 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHETAMIN 15 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMP-AMPHETAMIN 15 MG TAB?
DEXTROAMP-AMPHETAMIN 15 MG TAB (NDC 42858072501) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.